News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
841,703 Results
Type
Article (86184)
Company Profile (702)
Press Release (754817)
Section
Business (232544)
Career Advice (4123)
Deals (39708)
Drug Delivery (127)
Drug Development (90899)
Employer Resources (196)
FDA (18058)
Job Trends (17309)
News (396158)
Policy (39686)
Tag
2024 BioCapital Digital (20)
2024 BioForest Digital (16)
2024 BioForest Standard (1)
2024 BioMidwest Digital (14)
2024 BioMidwest Standard (2)
2024 Bio NC Digital (19)
2024 Bio NC Standard (2)
2024 Biotech Bay Standard (20)
2024 Biotech Beach Digital (15)
2024 Biotech Beach Standard (9)
2024 Genetown Digital (10)
2024 Genetown Standard (12)
2024 Lone Star Bio Digital (17)
2024 Pharm Country Digital (13)
2024 Pharm Country Standard (7)
2025 BioForest Digital (13)
2025 Lone Star Bio Digital (16)
2026 BioCapital Elite (1)
2026 BioCapital Standard (1)
2026 BioMidwest Elite (2)
2026 Biotech Bay Elite (1)
2026 Biotech Bay Standard (1)
2026 Biotech Beach Elite (2)
2026 Genetown Elite (3)
2026 Pharm Country Elite (1)
2026 Pharm Country Premier (1)
2026 Pharm Country Standard (1)
Academia (2989)
Academic (2)
Accelerated approval (3)
Adcomms (29)
Allergies (84)
Alliances (56735)
ALS (88)
Alzheimer's disease (1446)
Antibody-drug conjugate (ADC) (130)
Approvals (18012)
Artificial intelligence (283)
Autoimmune disease (16)
Automation (14)
Bankruptcy (403)
Best Places to Work (12633)
BIOSECURE Act (21)
Biosimilars (107)
Biotechnology (481)
Bladder cancer (57)
Brain cancer (29)
Breast cancer (260)
Cancer (1987)
Cardiovascular disease (162)
Career advice (3525)
Career pathing (32)
CAR-T (154)
Cell therapy (441)
Cervical cancer (16)
Clinical research (72873)
Collaboration (787)
Compensation (433)
Complete response letters (29)
COVID-19 (2852)
CRISPR (41)
C-suite (208)
Cystic fibrosis (104)
Data (1829)
Decentralized trials (2)
Denatured (42)
Depression (49)
Diabetes (255)
Diagnostics (6858)
Digital health (19)
Diversity (9)
Diversity, equity & inclusion (48)
Drug discovery (135)
Drug pricing (122)
Drug shortages (33)
Duchenne muscular dystrophy (76)
Earnings (95863)
Editorial (38)
Employer branding (25)
Employer resources (167)
Events (128856)
Executive appointments (649)
FDA (19131)
Featured Employer (66)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (7)
Funding (705)
Gene editing (105)
Generative AI (32)
Gene therapy (311)
GLP-1 (800)
Government (5107)
Grass and pollen (4)
Guidances (47)
Healthcare (20862)
Huntington's disease (24)
IgA nephropathy (24)
Immunology and inflammation (114)
Indications (25)
Infectious disease (2989)
Inflammatory bowel disease (143)
Inflation Reduction Act (11)
Influenza (48)
Intellectual property (77)
Interviews (811)
IPO (17788)
IRA (51)
Job creations (5184)
Job search strategy (2860)
Kidney cancer (10)
Labor market (34)
Layoffs (527)
Leadership (19)
Legal (10094)
Liver cancer (76)
Lung cancer (288)
Lymphoma (130)
Machine learning (2)
Management (65)
Manufacturing (293)
MASH (63)
Medical device (14550)
Medtech (14555)
Mergers & acquisitions (22342)
Metabolic disorders (690)
Multiple sclerosis (69)
NASH (23)
Neurodegenerative disease (90)
Neuropsychiatric disorders (30)
Neuroscience (1952)
NextGen: Class of 2025 (7679)
Non-profit (5077)
Northern California (2336)
Now hiring (37)
Obesity (382)
Opinion (265)
Ovarian cancer (64)
Pain (83)
Pancreatic cancer (75)
Parkinson's disease (134)
Partnered (20)
Patents (199)
Patient recruitment (89)
Peanut (50)
People (64947)
Pharmaceutical (143)
Pharmacy benefit managers (21)
Phase I (22478)
Phase II (31642)
Phase III (23841)
Pipeline (896)
Podcasts (117)
Policy (129)
Postmarket research (3552)
Preclinical (10075)
Press Release (72)
Prostate cancer (91)
Psychedelics (38)
Radiopharmaceuticals (266)
Rare diseases (387)
Real estate (7384)
Recruiting (75)
Regulatory (26538)
Reports (54)
Research institute (2652)
Resumes & cover letters (649)
Rett syndrome (3)
RNA editing (2)
RSV (45)
Schizophrenia (73)
Series A (126)
Series B (75)
Service/supplier (29)
Sickle cell disease (55)
Southern California (2034)
Special edition (18)
Sponsored (33)
Startups (4284)
State (2)
Stomach cancer (15)
Supply chain (65)
The Weekly (74)
United States (21515)
Vaccines (753)
Venture capitalists (37)
Webinars (13)
Weight loss (284)
Women's health (36)
Worklife (17)
Date
Today (72)
Last 7 days (641)
Last 30 days (3292)
Last 365 days (36996)
2025 (7243)
2024 (38138)
2023 (42568)
2022 (53928)
2021 (58724)
2020 (57666)
2019 (51338)
2018 (39124)
2017 (37191)
2016 (38330)
2015 (44433)
2014 (39673)
2013 (36268)
2012 (38416)
2011 (38383)
2010 (39616)
Location
Africa (1270)
Alabama (55)
Alaska (7)
Arizona (252)
Arkansas (13)
Asia (49870)
Australia (8790)
California (5481)
Canada (1844)
China (457)
Colorado (251)
Connecticut (278)
Delaware (129)
Europe (114292)
Florida (798)
Georgia (193)
Hawaii (1)
Idaho (64)
Illinois (559)
India (26)
Indiana (305)
Iowa (8)
Japan (135)
Kansas (106)
Kentucky (27)
Louisiana (11)
Maine (68)
Maryland (867)
Massachusetts (4269)
Michigan (231)
Minnesota (384)
Mississippi (2)
Missouri (83)
Montana (31)
Nebraska (26)
Nevada (56)
New Hampshire (68)
New Jersey (1564)
New Mexico (31)
New York (1556)
North Carolina (1039)
North Dakota (8)
Northern California (2336)
Ohio (195)
Oklahoma (14)
Oregon (47)
Pennsylvania (1221)
Puerto Rico (8)
Rhode Island (27)
South America (1649)
South Carolina (17)
South Dakota (1)
Southern California (2034)
Tennessee (90)
Texas (821)
Utah (169)
Virginia (144)
Washington D.C. (64)
Washington State (542)
West Virginia (3)
Wisconsin (60)
There are 841,703 results that match your search.
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Medexus Completes Agreement to Return US Commercialization Rights for Gleolan to NX Development Corp.
March 14, 2025
·
4 min read
GLP-1
Altimmune To Test Investigational GLP-1–Based Obesity Drug for Alcohol Use Disorder
The Maryland-based biopharma joins Eli Lilly and Novo Nordisk in trialing a GLP-1 agonist for alcohol- and liver-related conditions.
March 14, 2025
·
1 min read
·
Dan Samorodnitsky
Layoff Tracker
GRO Biosciences Cuts Staff Amid Quest for Strategic Alternatives
2024 was a tough year for the biopharma industry, with several companies cutting hundreds or even thousands of employees. Follow along as
BioSpace
tracks job cuts and restructuring initiatives throughout 2025.
March 14, 2025
·
143 min read
·
BioSpace Editorial Staff
Pipeline
Pfizer’s Pipeline Pruning Ends Early-Stage STING Trial
Pfizer was studying PF-07820435, an orally available agonist of the STING protein, for solid tumors.
March 14, 2025
·
2 min read
·
Tristan Manalac
Layoffs
Sutro Cuts Half of Staff, Deprioritizes ADC in Strategic Review
Sutro’s stock tumbled nearly 19% after the company announced it will sideline its FRα-targeted antibody-drug conjugate luveltamab tazevibulin, which it was studying for ovarian cancer. The biotech will seek licensing opportunities for the asset.
March 14, 2025
·
3 min read
·
Tristan Manalac
Business
Pliant Pops Poison Pill as Concentra Threat Looms
Pliant follows in the footsteps of Acelyrin, which also enacted a stockholder rights program on Thursday to protect shareholders against Tang Capital’s growing stake in the company.
March 14, 2025
·
2 min read
·
Tristan Manalac
Government
FDA Makes Flu Vaccine Recommendations Without Convening Advisors
The recommendations were made in a closed session with representatives from CBER, the CDC and Department of Defense.
March 14, 2025
·
2 min read
·
Tristan Manalac
Press Releases
Skye Bioscience to Announce 2024 Financial Results on March 20th, 2025
March 14, 2025
·
3 min read
Press Releases
China’s First IGF-1R Monoclonal Antibody: Innovent Announces NMPA approval of SYCUME® for the Treatment of Thyroid Eye Disease
March 14, 2025
·
10 min read
Press Releases
Accropeutics Secured $12 Million in Series B Plus Financing
March 14, 2025
·
2 min read
1 of 84,171
Next
